[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Novartis AG Graphic](https://lunarcrush.com/gi/w:26/t:novartis.png) Novartis AG (NVS)

Novartis receives approval for the first malaria treatment for babies, while also facing generic competition for Entresto after a patent setback. The company's stock is up XXX% due to positive news.

### About Novartis AG
Novartis AG (NVS) is a pharmaceutical company.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/novartis/insights)
- Novartis AG (NVS) social dominance is at XXXXX which is XXX% higher than it's daily average.
- Novartis AG (NVS) mentions is at XXX which is XXX% higher than it's daily average.
- Novartis AG (NVS) mentions near a 52-week high at XXX.
- Novartis AG (NVS) creators is at XXX which is XXX% higher than it's daily average.
- Novartis AG (NVS) trading volume is up XXXXX% from the previous week.
- Novartis AG (NVS) social dominance is up XXXXXX% from the previous year.
- Novartis AG Mentions hit a high of XXX for the day
- Novartis AG Mentions hit an all time of XXX for the day

### Price: $XXXXXX [#](/topic/novartis/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/novartis/time-series/close.tsv)  
The current price increase of XXX% is likely influenced by positive news surrounding the approval of the new malaria treatment for babies, despite a recent patent setback.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | -XXXX% |

**1-Year High**: $XXXXXX on 2025-07-02  
**1-Year Low**: $XXXXX on 2024-12-19  
  
  
### AltRank: XXX [#](/topic/novartis/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #725 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +18  
**1 Month**: XXX -XXX  
**6 Months**: XXX +75  
**1 Year**: XXX +148  
**1-Year High**: XXXXX on 2025-02-18  
**1-Year Low**: XX on 2024-07-28  
  
  
### Galaxy Score: XXXXX [#](/topic/novartis/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/novartis/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -X  
**1 Month**: XX -X  
**6 Months**: XX -X  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-05-20  
**1-Year Low**: XX on 2024-10-20  
  
  
### Engagements: XXXXXX [#](/topic/novartis/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/novartis/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXXXX -XXXX%  
**6 Months**: XXXXXXXXXX +37%  
**1 Year**: XXXXXXXXXX -XX%  
**1-Year High**: XXXXXXXXX on 2024-12-26  
**1-Year Low**: XXXXX on 2025-07-19  

| Social Network | X      | Reddit | YouTube | TikTok | News |
| -------------- | -      | ------ | ------- | ------ | ---- |
| Engagements    | XXXXXX | XX     | XXXXX   | XXXXX  | XXX  |
  

  
  
### Mentions: XXX [#](/topic/novartis/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/novartis/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXX +7.80%  
**6 Months**: XXXXXX +145%  
**1 Year**: XXXXXX +89%  
**1-Year High**: XXX on 2025-07-18  
**1-Year Low**: XX on 2024-09-15  

| Social Network | X   | Reddit | YouTube | TikTok | News |
| -------------- | -   | ------ | ------- | ------ | ---- |
| Mentions       | XXX | XX     | XXX     | XX     | XX   |
  

  
  
### Creators: XXX [#](/topic/novartis/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/novartis/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is up XXXX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +6.50%  
**6 Months**: XXXXX +128%  
**1 Year**: XXXXX +123%  
**1-Year High**: XXX on 2025-04-11  
**1-Year Low**: XX on 2024-09-15  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                            | Rank | Followers  | Posts | Engagements |
| -------                                            | ---- | ---------  | ----- | ----------- |
| [@Reuters](/creator/twitter/Reuters)               | X    | XXXXXXXXXX | X     | XXXXX       |
| [@novartis](/creator/youtube/novartis)             | X    | XXXXXX     | X     | XXXXX       |
| [@ValueSense_io](/creator/twitter/ValueSense_io)   | X    | XXXXXX     | X     | XXXXX       |
| [@YahooFinance](/creator/youtube/YahooFinance)     | X    | XXXXXXXXX  | X     | XXXXX       |
| [@business](/creator/twitter/business)             | X    | XXXXXXXXX  | X     | XXX         |
| [@cnbctelevision](/creator/youtube/cnbctelevision) | X    | XXXXXXXXX  | X     | XXX         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)     | X    | XXXXX      | X     | XXX         |
| [@MartyChargin](/creator/twitter/MartyChargin)     | X    | XXXXXX     | X     | XXX         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: XX% [#](/topic/novartis/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/novartis/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% +1%  
**1 Month**: XX% -X%  
**6 Months**: XX% +7%  
**1 Year**: XX% +1%  
**1-Year High**: XXX% on 2024-08-24  
**1-Year Low**: XX% on 2024-08-13  

**Most Supportive Themes**
- **New Malaria Treatment Approval:** (50%) Novartis received Swiss approval for Coartem Baby, the first malaria treatment for newborns, generating significant positive engagement on social media.
- **Indian Origin CEO's:** (20%) Mentions of Novartis and its CEO being Indian-origin are trending positively across social media.
  
**Most Critical Themes**
- **Drug Trial Failure:** (4%)  A Novartis drug, Secukinumab, failed in a late-stage trial for treating blood vessel inflammation.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXXX  | XX% | XXXXX    | XX% |
| Reddit  | XX       | X%  | XX      | X%  | XX       | X%  |
| YouTube | XXXXX    | X%  | XXXXX   | XX% | XXX      | X%  |
| TikTok  | XXXXX    | X%  | XXXXX   | XX% | XX       | X%  |
| News    | XX       | X%  | XX      | X%  | XXX      | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | XX% |
  

  
  
### Social Dominance: XXXX% [#](/topic/novartis/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/novartis/time-series/social_dominance.tsv)  
**Current Value**: XXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.024%  
**1 Month**: XXXXX% +0.235%  
**6 Months**: XXXXX% +0.358%  
**1 Year**: XXXXX% +0.42%  
**1-Year High**: XXXXX% on 2025-07-19  
**1-Year Low**: XXXXX% on 2024-08-03  
  
  
### Market Dominance: XXXXX% [#](/topic/novartis/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/novartis/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2024-12-16  
  
  
### Market Cap: $XXXXXXXXXXXXXXX [#](/topic/novartis/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/novartis/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXXX +$2.30%  
**1 Month**: $XXXXXXXXXXXXXXX +$6.70%  
**6 Months**: $XXXXXXXXXXXXXXX +$25%  
**1 Year**: $XXXXXXXXXXXXXXX +$13%  
**1-Year High**: $XXXXXXXXXXXXXXX on 2024-08-30  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2024-12-19  

**Top assets mentioned**
In the posts about Novartis AG in the last XX hours

[Novartis AG (NVS)](/topic/$nvs)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Alphabet Inc Class A (GOOGL)](/topic/$googl)
[Arcblock (ABT)](/topic/$abt)
[Microsoft Corp. (MSFT)](/topic/microsoft)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Sanofi (SNY)](/topic/sanofi)

**Top topics mentioned**
In the posts about Novartis AG in the last XX hours

[$novnsw](/topic/$novnsw), [stocks healthcare](/topic/stocks-healthcare), [$nvs](/topic/$nvs), [babies](/topic/babies), [stocks](/topic/stocks), [stocks technology](/topic/stocks-technology), [tariffs](/topic/tariffs), [eps](/topic/eps), [coins healthcare](/topic/coins-healthcare), [$pfe](/topic/$pfe), [adobe](/topic/adobe), [youtube](/topic/youtube), [india](/topic/india), [drugs](/topic/drugs), [investment](/topic/investment), [netapp](/topic/netapp), [switzerland](/topic/switzerland), [approved](/topic/approved), [cnbc](/topic/cnbc), [$mrk](/topic/$mrk), [money](/topic/money), [$googl](/topic/$googl), [coins ai](/topic/coins-ai), [careers](/topic/careers), [bloomberg](/topic/bloomberg), [$10b](/topic/$10b), [$baynsg](/topic/$baynsg), [$abt](/topic/$abt), [$novn](/topic/$novn), [chanel](/topic/chanel), [$1405b](/topic/$1405b), [novo](/topic/novo), [eli](/topic/eli), [world of](/topic/world-of), [donald trump](/topic/donald-trump), [$novcde](/topic/$novcde), [breakthrough](/topic/breakthrough), [$sdzsw](/topic/$sdzsw), [pep](/topic/pep), [stocks communication services](/topic/stocks-communication-services), [microsoft](/topic/microsoft), [$pubpa](/topic/$pubpa), [#fyp](/topic/#fyp), [acquisition](/topic/acquisition), [$1402b](/topic/$1402b), [saving](/topic/saving), [$vlvof](/topic/$vlvof), [quarterly earnings](/topic/quarterly-earnings), [gabriel](/topic/gabriel), [$abbv](/topic/$abbv), [$amgn](/topic/$amgn), [sap](/topic/sap), [$mngl](/topic/$mngl), [stockmarket](/topic/stockmarket), [insurance](/topic/insurance), [publicis groupe](/topic/publicis-groupe), [cash flow](/topic/cash-flow), [sanofi](/topic/sanofi), [eli lilly](/topic/eli-lilly), [ibkr](/topic/ibkr), [marsh](/topic/marsh), [volvo](/topic/volvo), [china](/topic/china), [don t](/topic/don-t), [$bgne](/topic/$bgne), [$6160hk](/topic/$6160hk), [jersey](/topic/jersey), [$asazy](/topic/$asazy), [$abbny](/topic/$abbny), [realdonaldtrump](/topic/realdonaldtrump), [united states](/topic/united-states), [wellness](/topic/wellness), [$xbi](/topic/$xbi), [cfg](/topic/cfg), [$0981hk](/topic/$0981hk), [new york stock exchange](/topic/new-york-stock-exchange), [$tsm](/topic/$tsm), [london](/topic/london), [$ezjl](/topic/$ezjl), [coins energy](/topic/coins-energy), [manat](/topic/manat), [fed](/topic/fed), [$issc](/topic/$issc), [germany](/topic/germany), [$vlvly](/topic/$vlvly), [potus](/topic/potus), [$gmabco](/topic/$gmabco), [coins analytics](/topic/coins-analytics), [nbc](/topic/nbc), [japan](/topic/japan), [longterm](/topic/longterm), [asml](/topic/asml), [op](/topic/op), [taiwan](/topic/taiwan), [jnj](/topic/jnj), [ireland](/topic/ireland), [transformative](/topic/transformative), [uganda](/topic/uganda), [welcome to](/topic/welcome-to), [united states dollar](/topic/united-states-dollar)

### Top News [#](/topic/novartis/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Tariffs are an overhang on pharma sector but we will comeback says Novartis CEO Vas Narasimhan"  
[@CNBC](/creator/x/CNBC) on [X](/post/news/cnbc.com-1125963047) 2025-07-17 15:40:41 UTC 208.1M followers, XXX engagements


"Trending tickers: TSMC Netflix Rigetti Novartis and EasyJet"  
[@YahooFinance](/creator/x/YahooFinance) on [X](/post/news/uk.finance.yahoo.com-144852910) 2025-07-17 08:42:28 UTC 208.1M followers, XX engagements


"Novartis Q2 profit rises XX% on strong U.S. sales of Kisqali and Entresto By Investing.com"  
[@Investingcom](/creator/x/Investingcom) on [X](/post/news/investing.com-465887787) 2025-07-17 05:31:51 UTC 1.3M followers, XX engagements


"Novartis CFO Plans to Retire Psoriasis Drug Disappoints - Bloomberg"  
[@business](/creator/x/business) on [X](/post/news/bloomberg.com-3656971888) 2025-07-17 05:22:51 UTC 9.7M followers, 21K engagements



### Top Social Posts [#](/topic/novartis/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Top is in when we see "Novartis the makers of Gas-X launch a Fartcoin treasury strategy""  
[@OriginalJakeW](/creator/x/OriginalJakeW) on [X](/post/tweet/1946296287089086668) 2025-07-18 19:49:29 UTC XXX followers, XX engagements


"Several AAV-based gene therapies may face heightened FDA surveillance due to shared risks like liver toxicity highlighted by Sarepta's Elevidys deaths: - Novartis: Zolgensma (SMA) - Roche/Spark: Luxturna (retinal dystrophy) - CSL Behring: Hemgenix (hemophilia B) - BioMarin: Roctavian (hemophilia A) Pipeline: Pfizer (foro DMD) Solid Biosciences (SGT-003 DMD). Pharma pullbacks (e.g. Vertex Pfizer) signal broader safety reevaluation"  
[@grok](/creator/x/grok) on [X](/post/tweet/1946271610941718694) 2025-07-18 18:11:26 UTC 5.2M followers, XXX engagements


"Novartis Chief Warns Of Fewer Launches And Drug Withdrawals In Europe Click image below to read more #Scrip Start your free trial today:"  
[@PharmaScrip](/creator/x/PharmaScrip) on [X](/post/tweet/1946266466879205843) 2025-07-18 17:51:00 UTC 21.6K followers, XXX engagements


"What's New to The Street. Novartis Launches $10B Buyback & Raises Profit Outlook 💊📈 Novartis announces a buyback of up to $XX billion while lifting its profit outlook fueled by strong performance from its newly launched drugs proving the strength of its evolving portfolio. @vincemedia1 Innovation driving results. 💬 Whats your take on pharmas market momentum Share your thoughts below 👇🏻 Follow @NewToTheStreet for more business news and market updates. #Novartis #PharmaNews #Innovation #Businessupdate #Businessnews #Business #News#Newtothestreet"  
[@NewToTheStreet](/creator/x/NewToTheStreet) on [X](/post/tweet/1946262332923076879) 2025-07-18 17:34:34 UTC 72.2K followers, XXX engagements